Hired and Retired: Regulatory turbulence shakes the space
The end of the summer sees several leading companies, including Regeneron, Novartis, and Bayer, experience changes in their leadership.
The end of the summer sees several leading companies, including Regeneron, Novartis, and Bayer, experience changes in their leadership.
Chr. Hansen and Lonza name their joint venture CDMO for live biotherapeutics and ready the launch after receiving antitrust approvals.